
About Zeke Pharmaceuticals Private Limited
Data last updated:
Zeke Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24200KA2016PTC098367. Its GSTIN is 29AABCZ0256F1ZC (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Laxmi Krishnappa Pujar and Chittannavar Madhegowda Raju.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at No. 5/1 Shop No. 3 Nagarbavi Main Road Maruti Nagar, Bangalore, Karnataka, India – 560072.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zekepharma.com.
Company details
Contact details
Zeke Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is zekepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo. 5/1 Shop No. 3 Nagarbavi Main Road Maruti Nagar, Bangalore, Karnataka, India – 560072
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Zeke Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Zeke Pharmaceuticals Private Limited
FY 2022 filings availableZeke Pharmaceuticals Private Limited reported revenue of ₹6,381 (down 100% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 88% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zeke Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zeke Pharmaceuticals Private Limited
Zeke Pharmaceuticals has 2 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Laxmi Krishnappa Pujar | Director | 06 Dec 2021 | 4 Years 11 Months | Current |
| Chittannavar Madhegowda Raju | Director | 08 Nov 2021 | 5 Years 0 Months | Current |
Peer comparison
Zeke Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Astrik Pharmaceuticals Private Limited | ₹6,804 (FY 2022) | 1225.0% | Lucknow, Uttar Pradesh, India | |||
| Isis Pharmaceuticals Private Limited | ₹6,600 (FY 2024) | -5.0% | Harnana, Haryana, India | |||
| Gpsons Pharmaceuticals Private Limited | ₹6,504 (FY 2024) | 18.0% | Gorakhpur, Uttar Pradesh, India | |||
| Haben Pharmaceuticals Private Limited | ₹6,500 (FY 2021) | -93.0% | Baramulla, Jammu and Kashmir, India | |||
| Biosper Pharmaceuticals Private Limited | ₹6,450 (FY 2025) | 42.0% | Bangalore, Karnataka, India | |||
| Zeke Pharmaceuticals Private Limitedthis company | ₹6,381 (FY 2022) | -100.0% | Bangalore, Karnataka, India | |||
| SDS Pharmaceuticals Private Limited | ₹6,200 (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Kanodia Pharmaceuticals Private Limited | ₹6,000 (FY 2018) | Delhi, India | ||||
| GP Rules Pharmaceuticals Private Limited | ₹6,000 (FY 2025) | Raebareli, Uttar Pradesh, India | ||||
| Berwind Pharmaceuticals Services Private Limited | ₹5,940 (FY 2022) | -42.0% | Betalbatim, Goa, India | |||
| Neuvocare Pharmaceuticals Private Limited | ₹5,901 (FY 2024) | Nashik, Maharashtra, India |
To see the full peer comparison of Zeke Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Zeke Pharmaceuticals Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Zeke Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zeke Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zeke Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zeke Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCZ0256F1ZC | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zeke Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zeke Pharmaceuticals Private Limited has 13 board changes on record since 2018: 2 appointments and 11 cessations. The latest: Madaiah Mangala ceased to be Director on 10 Apr 2022.
4 earlier events are in the company report.
Frequently asked questions
Zeke Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 December 2016 (10+ years old) and is registered under CIN U24200KA2016PTC098367.
Zeke Pharmaceuticals has 2 current directors:
- Laxmi Krishnappa Pujar - Director
- Chittannavar Madhegowda Raju - Director
The latest financial statements of Zeke Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Zeke Pharmaceuticals is 29AABCZ0256F1ZC, registered in Karnataka.
The CIN (Corporate Identification Number) of Zeke Pharmaceuticals is U24200KA2016PTC098367. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zeke Pharmaceuticals was incorporated on 09 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Zeke Pharmaceuticals by revenue are Astrik Pharmaceuticals Private Limited, Isis Pharmaceuticals Private Limited, Gpsons Pharmaceuticals Private Limited, Haben Pharmaceuticals Private Limited, Biosper Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Madaiah Mangala ceased to be Director on 10 Apr 2022. Khaja Moinuddin ceased to be Director on 08 Apr 2022. Laxmi Krishnappa Pujar was appointed as Director on 06 Dec 2021. Zeke Pharmaceuticals has 13 board changes on record in total.
Zeke Pharmaceuticals can be reached through the website zekepharma.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Zeke Pharmaceuticals is at No. 51 Shop No. 3 Nagarbavi Main Road Maruti Nagar, Bangalore, Karnataka, India – 560072.
Zeke Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

